Navigation Links
Cytos VLP Platform is Basis for Phase 1 Clinical Trial with Anti-IgE Vaccine
Date:2/3/2013

ZURICH, February 4, 2013 /PRNewswire/ --

Cytos Biotechnology Ltd (SIX:CYTN) has been informed by Pfizer Inc. that the first patient has been dosed in a Phase 1 clinical trial with an anti-IgE vaccine, which is being developed under a license agreement between both parties. Pfizer's anti-IgE vaccine is based on Cytos' VLP ("virus-like-particle") vaccine platform.

Christian Itin , Chairman and Chief Executive Officer of Cytos, comments: "We are very pleased that Pfizer has advanced its anti-IgE vaccine to a Phase 1 clinical trial. This is an important milestone for the program and provides further evidence of the potential of Cytos' B-cell vaccine platform based on Qbeta-derived virus like particles."

Pfizer acquired world-wide exclusive rights to develop, manufacture and commercialize certain specified vaccines based on Cytos' VLP platform in 2009.

About Cytos Biotechnology Ltd

Cytos is a public biopharmaceutical company focused on the development of targeted immuno-therapies. The Company's lead product candidate CYT003 is a first-in-class biologic in Phase 2 clinical development as a potential new treatment for allergic asthma.

CYT003 acts via a novel, allergen-independent mechanism of action to selectively suppress the body's immune response to allergens, a predominant risk factor for asthma. In a successfully completed Phase 2a study, CYT003 was shown to maintain asthma control and lung function and asthma control in patients with persistent allergic asthma, even as standard inhaled corticosteroid treatment was withdrawn. CYT003 has been shown to be safe in over 450 patients to date.

Cytos was founded in 1995 as a spinoff from the Swiss Federal Institute of Technology (ETH) in Zurich. It is located in Schlieren (Zurich), Switzerland. The Company is listed according to the Main Stan
'/>"/>

SOURCE Cytos
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Cytos Biotechnology Ltd Reports Third Quarter 2012 Financial Results, Recent Development and Outlook
2. CytoSorbents Receives Approximately $400,000 in Non-Dilutive Capital from the Sale of Net Operating Loss Carryovers
3. Guangzhous Sun Yat-sen University Cancer Center Debuts MOSAIQ in the Chinese Platform
4. Effie Toshav Joins Fenwick - Broadens Life Sciences Service Platform
5. Simbionix Releases Two New Platforms at the Upcoming DDW and AUA Events
6. Mylan Sponsors Drug Store News and Pharmacist Society to Provide a New Business Networking Platform for Pharmacy Schools and Students
7. Aushon to Launch New Multiplex Immunoassay Platform
8. ZyDoc Selects Health Fidelitys REVEAL™ Natural Language Processing (NLP) Platform to Accelerate Time to Value for its MediSapien Web Services
9. iBio Announces Important Expansion of its Intellectual Property Portfolio: Allowance of Patent for Anthrax Vaccines and Further Application of Modulator Platform
10. Biosimilars in Emerging Economies - Advanced Recombinant Technology Platforms and Low Cost Manufacturing Put India and China at a Strategic Advantage in Biosimilar Production
11. WaferGen Bio-systems Launches MyDesign - Setting a New Standard in Flexibility with an Open Format High-Throughput qPCR Platform
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... and Markets ( http://www.researchandmarkets.com/research/63gppw/asian_dermatology ) has announced the ... by End User - Forecast to 2019" report to ... estimated to grow at a CAGR of 11.3% from 2014 ... share in the Dermatology devices market around 28.8% in 2014 ... Devices market holds a high potential for growth in future ...
(Date:5/1/2015)... At the American Association of Neurological Surgeons (AANS) Annual ... , Elekta will highlight Leksell Gamma Knife® Registry ... enormous amount of data – generated by thousands of ... advance clinical research and further optimize patient care. ... allows practitioners to store, retrieve, and analyze Gamma Knife ...
(Date:5/1/2015)... Calif., May 1, 2015 Pharmacyclics, Inc. (the ... for the quarter ended March 31, 2015, as well ... AbbVie Inc., no conference call will be held. ... quarter ended March 31, 2015 increased to $206 million ... 2014. , Worldwide IMBRUVICA ® (ibrutinib) net ...
Breaking Medicine Technology:Asian Dermatology Devices (Treatment & Diagnostic) Market by Type, by End User - Forecast to 2019 2Asian Dermatology Devices (Treatment & Diagnostic) Market by Type, by End User - Forecast to 2019 3Elekta to showcase Leksell Gamma Knife Registry at AANS Annual Meeting 2Elekta to showcase Leksell Gamma Knife Registry at AANS Annual Meeting 3Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 2Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 3Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 4Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 5Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 6Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 7Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 8Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 9Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 10Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 11Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 12Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 13Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 14Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 15Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 16Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 17Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 18Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 19Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 20Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 21Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 22Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 23Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 24Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 25Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 26Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 27Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 28Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 29Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 30Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 31Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 32
... WOODCLIFF LAKE, N.J., Oct. 14 Par Pharmaceutical Companies, Inc. ... a "Modified Dutch Auction" tender offer for a portion of ... 2010. , Under the "Modified Dutch Auction" procedure, Par is ... aggregate principal amount, or up to approximately 82.7%, of the ...
... In the United States, a woman is diagnosed with breast ... Except for skin cancers, breast cancer is the most ... To help fight this disease, eMed-ID, the world,s first emergency ... Personal Health Records (PHR) wristband sold to raise awareness during ...
Cached Medicine Technology:Par Pharmaceutical Announces 'Modified Dutch Auction' Tender Offer to Purchase up to $65,000,000 Aggregate Principal Amount of its Currently Outstanding 2.875% Senior Subordinated Convertible Notes due 2010 2Par Pharmaceutical Announces 'Modified Dutch Auction' Tender Offer to Purchase up to $65,000,000 Aggregate Principal Amount of its Currently Outstanding 2.875% Senior Subordinated Convertible Notes due 2010 3Par Pharmaceutical Announces 'Modified Dutch Auction' Tender Offer to Purchase up to $65,000,000 Aggregate Principal Amount of its Currently Outstanding 2.875% Senior Subordinated Convertible Notes due 2010 4Breast Cancer Survivors and Patients Encouraged to Have Medical History Readily Available 2Breast Cancer Survivors and Patients Encouraged to Have Medical History Readily Available 3
(Date:5/2/2015)... As one of only 30 Illinois companies to ... Achievement and Recognition Program (SHARP) certification, Essentra Specialty ... Illinois Department of Labor to host this special event. ... by the Occupational Safety and Health Administration’s (“OSHA”) Onsite ... meet or exceed all of the necessary regulations and ...
(Date:5/2/2015)... York, NY (PRWEB) May 02, 2015 ... when a deadly natural disaster strikes anywhere on this ... to leverage human sympathy and compassion for their own ... (United States Computer Emergency Readiness Team) issued an ... users “of potential email scams citing the earthquake in ...
(Date:5/2/2015)... As a nonsurgical staple in the ... neck and décolleté, radiofrequency energy is proving to ... the success of vulvovaginal rejuvenation. In a pilot ... ThermiGyn’s Women’s Health Clinical Advisory Board Chairman Red ... temperature controlled radio frequency, specifically that of ThermiVa, ...
(Date:5/1/2015)... 2015 Pioneer Millworks, the largest reclaimed ... in their reclaimed wood products at the 27th annual ... Center in NYC this May. Their newest offerings, Vat ... anticipated texture and color to North America's platform for ... texture and color in the design world and we're ...
(Date:5/1/2015)... (PRWEB) May 01, 2015 It’s raining bills ... House introducing proposals to expand federal support for telemedicine. ... that ATA has been working with Congress,” said Jonathan Linkous, ... signify how the nation is poised to embrace the use ... one more step in fulfilling ATA’s mission to improve quality, ...
Breaking Medicine News(10 mins):Health News:Essentra Specialty Tapes is Selected to Host Gov. Rauner and the Workers' Memorial Day Celebration 2Health News:Essentra Specialty Tapes is Selected to Host Gov. Rauner and the Workers' Memorial Day Celebration 3Health News:Cyber Aftershocks from Nepal’s Earthquake Can Cripple Businesses Right Here at Home 2Health News:Cyber Aftershocks from Nepal’s Earthquake Can Cripple Businesses Right Here at Home 3Health News:Cyber Aftershocks from Nepal’s Earthquake Can Cripple Businesses Right Here at Home 4Health News:Study Demonstrates Efficacy of Temperature Controlled Radiofrequency for Vulvovaginal Laxity 2Health News:Study Demonstrates Efficacy of Temperature Controlled Radiofrequency for Vulvovaginal Laxity 3Health News:Intensely Textured Reclaimed Wood to be Unveiled at ICFF in NYC by Pioneer Millworks 2Health News:Intensely Textured Reclaimed Wood to be Unveiled at ICFF in NYC by Pioneer Millworks 3Health News:ATA: Congress Floods the Halls with Telemedicine Proposals 2
... Services Panel That,Nursing Home Staffing and Quality Programs Are ... testimony,before a field hearing of the House Human Services ... (THCA) said that in order to,protect the Houston area,s ... essential in the year ahead to initiate a much-needed,discussion ...
... (IOF) has welcomed the recently published paper European ... in postmenopausal women(1) from the European Society for ... (ESCEO). , This paper constitutes a roadmap for ... tool based on the WHO technical report, Assessment ...
... access to top U.S. hospitals and doctors competing on the ... basis of quality, ... America (HPAM) offers,a specialty network for high value medical procedures ... rated medical centers,of excellence throughout the United States. These providers ...
... Online Ads, Bilingual Radio,Jingles, Resources for Parents, Older ... The Health Resources,and Services Administration (HRSA) has ... National Poison Prevention Week, March 16-22., The ... in the United States. This past year, more ...
... The American Academy of Cosmetic Surgery 2007 Procedural Survey ... 2226.3% increase in male sclerotherapy since ... of Cosmetic,Surgery (AACS) is pleased to announce the results ... polling the Academy,s U.S.-based,members., Findings conclude that sclerotherapy, ...
... the only curative treatment in patients with bile ... reliable diagnostic procedure is of great importance in ... the bile duct, imaging techniques including ultrasound, computed ... sensitivity for the detection of bile duct cancer. ...
Cached Medicine News:Health News:Increased Investment in Medicaid Needed to Protect Houston Area's Most Vulnerable Seniors, Disabled 2Health News:Increased Investment in Medicaid Needed to Protect Houston Area's Most Vulnerable Seniors, Disabled 3Health News:Increased Investment in Medicaid Needed to Protect Houston Area's Most Vulnerable Seniors, Disabled 4Health News:IOF recognizes ESCEO European guidance for osteoporosis diagnosis and management 2Health News:The Healthplace America(TM) Benefit Delivers a Better Option in Healthcare 2Health News:HRSA Launches Digital Campaign to Promote Poison Awareness and Prevention 2Health News:Men are Opting to Remove Spider Veins Over Replacing Hair 2
... Harmony Special Peristaltic phacoemulsification system features microprocessor ... individual programmability and remote control for all ... front panel with color coded function modes ... ease of use and viewing. Under control ...
The D.O.R.C. Silicone Oil is an ultra purified silicone oil which leads a maximum interfacial tension and minimizes interactions between tissues, cells and endo-tamponades media. (Sterile, 10 ml.)...
Eftiar® offers the vitreoretinal surgeon a temporary tamponade for efficient re-attachment of the retina, release of subretinal fluid, dissection of fibro-vascular proliferation and controlling r...
Silver Foley Catheter 2-way...
Medicine Products: